Precision Cancer Imaging market to reach $31.71 billion by 2030 at 12.8% CAGR, driven by increasing cancer prevalence and demand for personalized oncology treatments.
Pancreatic Stone Protein Testing market to reach $1.77 billion by 2030 at 7.8% CAGR, driven by rising hospital-acquired infections and POCT expansion.
Newborn Jaundice Treatment market to reach $3.49 billion by 2030 at 5.3% CAGR, driven by rising birth rates, neonatal care expansion, and adoption of advanced phototherapy systems.
Multicancer Early Detection DNA Blood Tests market to reach $1.49 billion by 2030 at 13.4% CAGR, driven by rising cancer prevalence, preventive healthcare awareness, and liquid biopsy adoption.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.